| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.00M | 886.46K | 468.51K | 110.14K | 23.94K | 21.28K |
| Gross Profit | 1.00M | 886.46K | 254.29K | -61.14K | -77.02K | -50.22K |
| EBITDA | -3.76M | -4.61M | 10.70M | -2.94M | -1.94M | -795.89K |
| Net Income | 45.75K | -439.53K | 10.37M | 4.98M | -2.15M | -1.04M |
Balance Sheet | ||||||
| Total Assets | 94.61M | 95.45M | 66.53M | 55.33M | 33.14M | 25.62M |
| Cash, Cash Equivalents and Short-Term Investments | 3.82M | 5.19M | 10.77M | 13.64M | 6.50M | 5.79M |
| Total Debt | 1.17M | 1.20M | 1.75M | 1.54M | 1.61M | 1.64M |
| Total Liabilities | 2.33M | 2.51M | 2.96M | 2.59M | 2.37M | 2.40M |
| Stockholders Equity | 92.27M | 92.94M | 63.57M | 52.75M | 30.76M | 23.22M |
Cash Flow | ||||||
| Free Cash Flow | -5.35M | -7.71M | -2.80M | -9.57M | -8.70M | -4.24M |
| Operating Cash Flow | -3.55M | -6.00M | -2.32M | -2.51M | -2.15M | -1.14M |
| Investing Cash Flow | -1.80M | 1.06M | -462.49K | -6.95M | -6.57M | -2.33M |
| Financing Cash Flow | -139.71K | -643.79K | -86.47K | 16.60M | 9.43M | 6.77M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
49 Neutral | AU$472.01M | -20.36 | -140.97% | ― | ― | ― | |
47 Neutral | AU$470.44M | -11.59 | -12.73% | ― | 2.00% | 8.82% | |
46 Neutral | AU$70.58M | -29.09 | -9.27% | ― | ― | 35.29% | |
46 Neutral | AU$87.64M | ― | -0.27% | ― | ― | -100.00% | |
44 Neutral | AU$126.58M | -6.14 | -21.39% | ― | ― | -280.00% | |
43 Neutral | AU$975.70M | -11.21 | -84.61% | ― | 149.43% | 1.20% |
Diatreme Resources has strengthened its financial position in the December 2025 quarter through the sale of its Clermont Copper/Gold Project to newly listed Moonlight Resources, in which it now holds a 16.76% stake. The transaction delivered $3.25 million in Moonlight shares and $250,000 in cash, while the company also received an R&D tax incentive refund of $226,894 related to its Cyclone Zircon Project and plans further claims for 2025 expenditure. Diatreme reported total cash and liquid assets of $7.7 million at 31 December 2025, including $5.4 million held within its silica project joint venture, providing additional funding runway as it advances its mineral sands and silica initiatives and continues investor engagement, including a CEO presentation at the Noosa Mining Investor Conference.
The most recent analyst rating on (AU:DRX) stock is a Sell with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.
Diatreme Resources Limited has submitted the Draft Environmental Impact Statement (DEIS) for its Northern Silica Project to Queensland’s Office of the Coordinator-General. This submission marks a significant milestone in the project’s approval process, highlighting its potential to deliver economic benefits and support the clean energy transition. The DEIS, prepared after extensive investigations, outlines the project’s scope, potential impacts, and mitigation strategies, paving the way for public consultation and review in 2026. The project promises new employment and investment opportunities for the Hope Vale/Cooktown region while managing environmental and cultural impacts.
The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.
Diatreme Resources Limited announced that Moonlight Resources Ltd, where it holds a 16.8% stake, has been listed on the Australian Securities Exchange. This follows Moonlight’s acquisition of Chalcophile Resources Pty Ltd and PGE Minerals Pty Ltd, which own the Clermont Gold Project. Moonlight has commenced drilling at the project, aiming for a Mineral Resource Estimate with results expected in Q1 2026. The IPO raised A$10 million, with Diatreme receiving shares and cash, and retaining the right to appoint a director to Moonlight’s board.
The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.
Diatreme Resources Limited has completed the sale of its Clermont Gold Project to Moonlight Resources Limited, receiving $3.25 million in Moonlight shares and $250,000 in cash. This transaction makes Diatreme a significant shareholder in Moonlight, with the right to appoint a director to Moonlight’s board, and it aligns with Moonlight’s upcoming IPO and ASX listing.
The most recent analyst rating on (AU:DRX) stock is a Hold with a A$0.02 price target. To see the full list of analyst forecasts on Diatreme Resources Limited stock, see the AU:DRX Stock Forecast page.
Diatreme Resources Limited announced that their resource estimates and production targets remain unchanged as of June 2025, with no new information affecting previous announcements. The company emphasizes the importance of securing project development finance and attracting financial partners to meet production targets, highlighting the ongoing demand for high purity silica sand in the market.
Diatreme Resources Limited announced a change in the director’s interest, with Karalyn Keys acquiring 2,546,253 ordinary shares through an on-market trade. This acquisition reflects a significant investment in the company, potentially indicating confidence in its future prospects and impacting its market positioning.